NBIX - Neurocrine releases new data on Ingrezza for Huntington's disease chorea
2023-08-28 10:50:19 ET
More on Neurocrine Biosciences
- Neurocrine Needs A Meaningful Clinical Win To Break Out, And Crinecerfont Could Do It
- Neurocrine Biosciences: Ingrezza Impresses Amid Costly Pipeline Expansion Efforts
- BMO upgrades Neurocrine to market perform on Ingrezza outlook
- Seeking Alpha’s Quant Rating on Neurocrine Biosciences
- Dividend for Neurocrine Biosciences
For further details see:
Neurocrine releases new data on Ingrezza for Huntington's disease chorea